(TAMPA, FL) CoreRx, an integrated contract development and manufacturing organization supporting the international pharmaceutical and biotechnology industries, has further enhanced its offering by adding the Bosch Manesty FLEXITAB®, A fully automated, single station tablet press with a multi-layer tablet function, giving it the unique capacity to produce multi-layer (up to three-layer) tablets using a minimal amount of material. Its variable punch displacement and dwell time can be set to simulate compression on any rotary press using compression forces up to100kN.
“CoreRx is continually assessing and investing in solutions to accelerate the manufacturing of our client’s clinical supplies, while ensuring quality at all times,” said Mark Licarde, CoreRx’s VP of Manufacturing. Licarde added: “We will continue to add to capabilities in response to client requirements for preclinical and early phase combination product clinical GMP supply. The FLEXITAB decreases setup time and API use – generating significant cost savings to our clients.”
Able to produce 3-layer tablets, the Bosch Manesty FLEXITAB® fully automated, single-station tablet press supports production of small batches. All parameters are adjustable, which allows for simulation of any rotary tablet press at any given speed. Hydraulic and pneumatic cylinders enable compression forces of 100 kN and rapid punch displacement. In addition, press includes TFT touch screen panel PC, PLC-based control system, and FLEXITAB software.
About CoreRx, Inc.
CoreRx™ focuses on supporting and streamlining the drug development process for biotechnology and pharmaceutical innovators by offering services such as pre-formulation/formulation development, analytical development, clinical manufacturing and validation engineering. We have a proven track record and extensive expertise providing comprehensive drug development services, particularly in the area of combination products, including multi-layer tablets, to biotechnology and pharmaceutical companies worldwide.
CoreRx, Inc. is a CGMP-compliant contract development and manufacturing facility. From its inception in 2006, CoreRx has been dedicated to solving scientific problems and providing expert pharmaceutical services to businesses required to meet the growing demand of pharmaceutical companies.
CoreRx Inc. (www.CoreRxPharma.com), headquartered in Tampa, FL, provides quality pharmaceutical formulation development, clinical trial material (Phase I, II and III) and commercial manufacturing, and analytical development/validation services to the pharmaceutical industry.
For more information, visit their website at www.corerxpharma.com, follow us on Twitter (http://twitter.com/#!/corerx), or call (813) 514-9399